We know the healthcare system won’t change overnight,
but with FoXX, we can change how women navigate it.
By investing in FoXX, you’re not just backing an app. You’re supporting a movement to close the data gap in women’s health and give millions of women the tools to advocate for better health outcomes.
Let’s build the future of women’s health together.
Fuel the future of women’s health
-
Massive unmet need
93% of women report their symptoms are dismissed, and conditions like endometriosis, PCOS, and autoimmune disorders take years to diagnose. FoXX is tackling one of healthcare’s biggest gaps.
-
Data advantage & clinical credibility
We’re officially licensed with the U.S. National Library of Medicine (UMLS, SNOMED CT, RxNorm, NIH CDEs, VSAC), giving FoXX access to the same medical standards providers use, and building a defensible moat.
-
First mover advantage
While period trackers dominate the market, no one is addressing women’s whole-body health with the depth, inclusivity, and clinical credibility of FoXX.
-
Built with women, backed by doctors
Our Advisory Committee of 100+ women, including patients, advocates, and healthcare providers, ensures FoXX is built on real needs and trusted medical standards.
-
Positioned for scale
Women’s health is a $1 trillion+ market opportunity. With early adopter demand, brand partnerships, and a scalable product roadmap, FoXX is set to become the leading platform for women’s health clarity and advocacy.
-
A daily companion app with stickiness
FoXX is designed for everyday use, creating habit-forming engagement that drives retention and lifetime value far beyond symptom logging apps.
